Inna C.
- Country
- Denmark
- Department
- Department of Oncology
Research Overview
- Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer with Actionable Molecular Alterations
- Phase 3 Randomized Trial of Daraxonrasib Monotherapy or Daraxonrasib + Gemcitabine/Nab‑Paclitaxel vs Gemcitabine/Nab‑Paclitaxel in First‑Line Metastatic Pancreatic Cancer
- Evaluation of mFOLFIRINOX With or Without BNT321 as Adjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma
Data & Insights
Has run more than one trial at 42 of 132 partner sites.
Specializations
Pancreatic Cancer Therapeutics
The investigator specializes in developing treatment approaches for pancreatic ductal adenocarcinoma (PDAC), with particular focus on both resectable and non-resectable cases. Their research encompasses adjuvant therapy strategies and treatment protocols for various stages of pancreatic cancer.
- Borderline Resectable Pancreatic Cancer
- Locally Advanced Pancreatic Cancer
- Metastatic Disease Management
Their work includes innovative combinations of immunotherapy with conventional chemotherapy and radiation treatments.
Multimodal Treatment Approaches
The investigator focuses on integrating multiple treatment modalities, including adaptive radiotherapy and combination chemotherapy regimens. Their expertise extends to personalized treatment strategies for fragile patients requiring modified therapeutic protocols.
- Combined Immunotherapy Protocols
- Adaptive Radiation Techniques
- Modified Chemotherapy Regimens
Special attention is given to developing treatment protocols that balance efficacy with patient tolerance.
Advanced Solid Tumors
The investigator's research extends to treating various malignant solid tumors, with expertise in managing multiple cancer types including melanoma, non-small cell lung cancer, and head and neck squamous cell carcinoma.
- Novel Therapeutic Combinations
- Refractory Disease Management
- Advanced Stage Cancer Treatment
Their work includes evaluating novel drug combinations and immunotherapy approaches for resistant cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.